-
Sector Analysis
Cystic Fibrosis – Global Drug Forecast and Market Analysis to 2030
The global (7MM) sales for the cystic fibrosis (CF) have been valued at $8.2 billion in 2020. The market is expected to grow at a CAGR of more than 4% during 2021-2025. Over the past decade, there have been significant changes in the CF market due to the development of CFTR modulator therapies that target the underlying cause of CF. Most of the sales has come from the US, which represents more than 75% of the market by 2030. The...
-
Product Insights
Erectile Dysfunction Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Erectile Dysfunction Global Clinical Trials Review, H1, 2018" provides an overview of Erectile Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Erectile Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Binge Eating Disorder: Opportunity Analysis and Forecasts to 2027
Binge eating disorder (BED) was first noted by Albert Stunkard in 1959, who described the consuming of large quantities of food at irregular intervals and its link to obesity. However, BED was only officially recognized as a distinct eating disorder in 2013, with the publication of the Diagnosis and Statistical Manual, Fifth Edition. Previously, the American Psychiatry Association (APA) had listed binge eating as a feature of eating disorders not otherwise specified. Since its recognition as a distinct clinical disorder,...
-
Product Insights
Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017" provides an overview of Female Hypoactive Sexual Desire Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Female Hypoactive Sexual Desire Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
OpportunityAnalyzer: Pulmonary Arterial Hypertension – Opportunity Analysis and Forecasts to 2026
Pulmonary arterial hypertension (PAH) is a rare, fatal cardiopulmonary disease with an annual mortality rate of 15%. The disease is a subset (Group 1) within the World Health Organization’s (WHO’s) classification of the different types of pulmonary hypertension (PH). PAH is characterized by an abnormal rise in the resting mean pulmonary arterial pressure (>25mmHg compared with normal levels of around 14mmHg). This increased pressure is caused by pulmonary arterial obstruction due to endothelial dysfunction and vascular remodeling, and leads to...
-
Product Insights
Male Sexual Dysfunction Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Male Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Male Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Male Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Female Hypoactive Sexual Desire Disorder Global Clinical Trials Review, H2, 2017" provides an overview of Female Hypoactive Sexual Desire Disorder clinical trials scenario. This report provides top line data relating to the clinical trials on Female Hypoactive Sexual Desire Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end...
-
Product Insights
Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Female Sexual Dysfunction Global Clinical Trials Review, H2, 2017" provides an overview of Female Sexual Dysfunction clinical trials scenario. This report provides top line data relating to the clinical trials on Female Sexual Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...